[1] 赵作勤,张君,王旭霞,等.口腔鳞癌综合序列治疗临床研究[J]. 中国实用口腔科杂志, 2010, 3(8): 469-471. [2] Hu HG, Scholten I, Gruss C, et al. The distribution of the DEK protein in mammalian chromatin [J]. Biochem Biophys Res Commun, 2007, 358(4): 1008-1014. [3] Waldmann T, Scholten I, Kappes F, et al. The DEK protein an abundant and ubiquitous constituent of mammalian chromatin [J]. Gene, 2004, 343(1): 1-9. [4] Waldmann T, Baack M, Richter N, et al. Structure-specific binding of the proto-oncogene protein DEK to DNA [J]. Nucleic Acids Res, 2003, 31(23): 7003-7010. [5] Waldmann T, Eckerich C, Baack M, et al. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils [J]. J Biol Chem, 2002, 277(28): 24988-24994. [6] Wise-Draper TM, Allen HV, Jones EE, et al. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions [J]. Mol Cell Biol, 2006, 26(20): 7506-7519. [7] Wise-Draper TM, Mintz-Cole RA, Morris TA, et al. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo [J]. Cancer Res, 2009, 69(5): 1792-1799. [8] Wu Q, Li Z, Lin H, et al. DEK overexpression in uterine cervical cancers [J]. Pathol Int, 2008, 58(6): 378-382. [9] Orlic M, Spencer CE, Wang L, et al. Expression analysis of 6p22 genomic gain in retinoblastoma [J]. Genes Chromosomes Cancer, 2006, 45(1): 72-82. [10] Carro MS, Spiga FM, Quarto M, et al. DEK Expression is controlled by E2F and deregulated in diverse tumor types [J]. Cell Cycle, 2006, 5(11): 1202-1207. [11] Sanchez-Carbayo M, Socci ND, Lozano JJ, et al. Gene discovery in bladder cancer progression using cDNA microarrays [J]. Am J Pathol, 2003, 163(2): 505-516. [12] Larramendy ML, Niini T, Elonen E, et al. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia.A microarray analysis [J]. Haematologica, 2002, 87(6): 569-577. [13] Kroes RA, Jastrow A, McLone MG, et al. The identification of novel therapeutic targets for the treatment of malignant brain tumors [J]. Cancer Lett, 2000, 156(2): 191-198. [14] Grottke C, Mantwill K, Dietel M, et al. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs [J]. Int J Cancer, 2000, 88(4): 535-546. [15] Kondoh N, Wakatsuki T, Ryo A, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis [J]. Cancer Res, 1999, 59(19): 4990-4996. [16] Kipp M, Göhring F, Ostendorp T, et al. SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA [J]. Mol Cell Biol, 2000, 20(20): 7480-7489. [17] Aravind L, Koonin EV. SAP a putative DNA-binding motif involved in chromosomal organization [J]. Trends Biochem Sci, 2000, 25(3): 112-114. [18] Cleary J, Sitwala KV, Khodadoust MS, et al. p300/CBP-associated factor drives DEK into interchromatin granule clusters[J]. J Biol Chem, 2005, 280(36): 31760-31767. [19] Kappes F, Burger K, Baack M, et al. Subcellular localization of the human proto-oncogene protein DEK [J]. J Biol Chem, 2001, 276(28): 26317-26323. [20] Saha AK, Kappes F, Mundade A, et al. Intercellular trafficking of the nuclear oncoprotein DEK [J]. Proc Natl Acad Sci USA, 2013, 110(17): 6847-6852. [21] Datta A, Adelson ME, Mogilevkin Y, et al. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer [J]. BMC Cancer, 2011, 11: 234. [22] Ratel RM, Walters LL, Kappes F, et al. DEK expression in Merkel cell carcinoma and small cell carcinoma [J]. J Cutan Pathol, 2012, 39(8): 753-757. |